hhg logo
hygeia logo
hospital logo
mitera logo
general logo
lito logo
creta interclinic logo
Απολλώνειο logo
aretaeio
health spot
business care
Platon Diagnosis
Hygeia IVF - Εμβρυογένεσις
alab
cityhospital
Heal Academy
business care
logimed
Prognosis
Dimokritos
Θεραπευτήριο Metropolitan Θεραπευτήριο Metropolitan
  • Ελληνικά
  • English
  • Home
  • About Us
    • About Metropolitan
    • Our Vision & Mission
    • Certifications
    • Testimonials
    • Facilities & Equipment
    • Quality & Patient Safety
    • Scientific Committee
    • Corporate Social Responsibility
  • International Patients
    • International Patients Department
    • Excellence in Medical Tourism
    • Request an Appointment
    • Personalized Travel Assistance
    • Billing Support
    • Medical Services
    • Outpatient Department
    • Specialized Units
    • Patients & Relatives
    • FAQs
    • Patient Instructions
  • Medical Services
    • General Services
    • Innovative Services
    • Specialized Units
    • Check-up
    • Emergency Department
    • Ambulances
    • Outpatient Department
    • Medical Tourism
    • COVID-19 TEST
  • Doctors
  • Gallery
  • Contact Us

Temos

  • DIAGNOSTIC LABS
  • DIAGNOSTIC LABS
  • Νοσοκομείο
  • Services
  • General Services
  • Diagnostic Labs
  • Team
  • TeamTeam
Subscribe to this RSS feed
Monday, 02 September 2024 10:29

MALTEZAS DIMITRIOS

Written by Redi Sorri
PROFILE

PROFILE

Consultant at the 2nd Hematology Clinic at Μetropolitan Hospital

EDUCATION & ACADEMIC TITLES

EDUCATION & ACADEMIC TITLES

May 2000: Degree in Medicine by the Medical School of Justus-Liebig University in Giessen, Germany

March 2010: Board certification in Hematology

December 2014: Dissertation by the Medical School of National and Capodistrian University of Athens, Greece: Study of the prognostic impact of serum free light chain ratio in patients with multiple myeloma. Investigation of biological mechanisms regulating secretion of free light chains by neoplasmatic plasma cells

PROFESSIONAL EXPERIENCE

PROFESSIONAL EXPERIENCE

  • 7/2000 – 1/2002 Residency in Internal Medicine Klinikum Offenbach, Germany
  • 3/2004 – 3/2005 Obligatory Service as General Practicioner
  • 5/2005 – 11/2005 Residency in Internal Medicine in the Hospital for special diseases in Thessaloniki, Greece
  • 11/2005 – 11/2009 Fellowship in Hematology in “Metaxa” hospital in Piraeus
  • 7/2010 – 2/2011 Hematologist, Tzaneio Hospital, Piraeus, Greece
  • 2/2011 – 12/2014 Hematologist, Florina General hospital, Greece
  • 1/2015 – 5/2015 Hematologist in the clinic for Hematology and Oncology of Marienhospital, Düsseldorf, Germany
  • 10/2015 – 5/2018 Hematologist, 1st Propedeutic Clinic for Internal Medicine, Laikon General Hospital, Athens, Greece
  • 6/2018 – 7/2022 Hematologist in “Metaxa” hospital in Piraeus
  • Since 8/2022 Hematologist in Metropolitan Hospital
MEMBERSHIP IN SOCIETIES & EDITORIAL BOARDS

MEMBERSHIP IN SOCIETIES & EDITORIAL BOARDS

  • Member of Medical Association of Piraeus
  • Member of Hellenic Hematology Association
  • Member of European Hematology Association
  • Reviewer for the scientific Magazine “Case reports in Hematology”
RESEARCH PROGRAMS

RESEARCH PROGRAMS

  • Subinvestigator in MiraCLLe Study: An Epidemiological, Prospective, two-year cohort study to Record the True First- and Second-Line Treatment Strategy, in Daily Clinical Practice, Metropolitan Hospital
DISTINCTIONS & AWARDS

DISTINCTIONS & AWARDS

  • “Young Investigator Award” for the following oral presentation in the Sixth International Workshop on Waldenstrom’s Macroglobulinemia, October 6 – 10 2010, Venice, Italy.
    Clinical impact of increased serum free light chains (sFLCs) or their ratio (FLCR) on WM at diagnosis and during disease course.
    D. Maltezas, T. Tzenou, N. Kafassi, E. Koulieris, V. Bartzis, M. Dimou, A. Efthymiou, G. Georgiou, T.P. Vassilakopoulos, M.K. Angelopoulou, P. Tsaftaridis, P. Panayiotidis, P. Beris, M-C Kyrtsonis.
    Quantification of serum IgM kappa and IgM lambda in patients with Waldenstrom’s Macroglobulinemia.
    E. Koulieris, M-C Kyrtsonis, D. Maltezas, T. Tzenou, L. Mirbahai, G. Mead, P. Panayiotidis, A.R. Bradwell, S. Harding.
  • Award for best Poster in its category. 7TH International Symposium on Clinical Applications of FLC & HLC, Edinburgh, UK, 16-17/6/15 για την εργασία:
    Serum free light chain (FLC) and soluble syndecan-1 levels are major markers of disease evolution of smoldering multiple myeloma (SMM) patients.
    Nikolaou E, Maltezas D, Koulieris E, Iliakis T, Viniou NA, Kotsanti S, Bitsani A, Bartzis V, Tzenou T, Dimou M, Panayiotidis P, Kyrtsonis MC.
    Hematology Reports 2015; 7(s1), pp28
PUBLICATIONS

PUBLICATIONS

  • Re-evaluation of prognostic markers including staging, serum free light chains or their ratio and serum lactate dehydrogenase in multiple myeloma patients receiving novel agents.
    Maltezas D, Dimopoulos MA, Katodritou I, Repousis P, Pouli A, Terpos E, P, Delimpasi S, Michalis E, Anargyrou K,Gavriatopoulou M, Stefanoudaki A, Tzenou T, Koulieris E, Sachanas S, Dimou M, Vassilakopoulos TP, Angelopoulou MK, Pangalis GA, MC. Hematol Oncol. 2012
  • Prognostic significance of serum free light chains in Chronic Lymphocytic Leukemia
    K. Sarris, D. Maltezas, E. Koulieris, V. Bartzis, T. Tzenou, S. Sachanas, E. Nikolaou, A. Efthymiou, K. Bitsani, M. Dimou, T. Vassilakopoulos, M. Siakantaris, M. Angelopoulou, F. Kontopidou, P. Tsaftaridis, N. Kafasi, G. Pangalis, P. Panayiotidis, S. Harding, M-C. Kyrtsonis.
    Adv Hematol. 2013;2013:359071
  • Contribution of new immunoglobulin-derived biomarkers in plasma cell dyscrasias and lymphoproliferative disorders.
    Kyrtsonis MC, Maltezas D, Koulieris E, Tzenou T, Harding SJ.
    WorldJHematol 2013; 2(2): 6-12
  • The contribution of prognostic factors to the better management of multiple myeloma patients.
    M-C Kyrtsonis, D Maltezas, E Koulieris, Catherine Bitsanis, Ilias Pessach, Anna Efthymiou, Vassiliki Bartzis, Tatiana Tzenou, Panayiotis Panayiotidis.
    Multiple Myeloma An Overview Chapter 8: Pages 145-174
  • Response to bortezomib in refractory/relapsed multiple myeloma patients: a single center experience with discussion on specific issues.
    M-C. Kyrtsonis, D. Maltezas, E. Koulieris, C. Zaroulis, T. Tzenou, S. Sachanas, V. Bartzis, G. Georgiou, M. Dimou, S. Siakavellas, T.P. Vassilakopoulos, M.K. Angelopoulou, E. Koutra, A. Mouzaki, G.A. Pangalis, P. Panayiotidis.
    The Asia-Pacific Journal of Oncology & Hematology 2010; Vol 1, Issue 4
  • Staging systems and prognostic factors as a guide to therapeutic decisions in multiple myeloma.
    M-C. Kyrtsonis, D. Maltezas, T. Tzenou, E. Koulieris, A.R. Bradwell.
    Seminars in Hematology. 2009 (2):110-7
  • Aberrant Immunoglobulin Variations as Indicators of Eventual Clonal Changes in Symptomatic Multiple Myeloma Patients' Course.
    Nikolaou E, Koulieris E, Maltezas D, Sarris A, Iliakis T, Vyniou N.A, Vardounioti I, Κarali V, Pessah I, Efthymiou A, Bitsani A, Bartzis V, Tzenou T, Dimou M, Vassilakopoulos TP, Angelopoulou ΜΚ, Tsaftaridis P, Tsalimalma K, Κafasi Ν, Panayiotidis P, Kyrtsonis M-C.
    CurrentCancerTherapyReviews, 2014, 10.2: 90-96
  • Biology and treatment of skeletal manifestations in multiple myeloma
    Stavropoulos N, Papadoyiannis A, Maltezas D, Stavrou P, Pangalis GA, Papagelopoulos PJ, Kyrtsonis MC.
    Journal of Cancer Therapy, 2014, 5, 387-402.
  • Prognostic contribution of new immunoglobulin biomarkers (Freelite, Hevylite) in Waldenstrom’s Macroglobulinemia (WM).
    MC Kyrtsonis, E. Koulieris, D. Maltezas, T. Tzenou, S. Harding, E. Kastritis, N. Kafassi, V. Bartzi, A. Efthymiou, K. Bitsanis, M. Gavriatopoulou, E. Terpos, C. Kalpadakis, M K Angelopoulou, T. P. Vassilakopoulos, AR Bradwell, PH. Berris, GA Pangalis, P. Panayiotidis, MA Dimopoulos
    American Journal of Medicine and Medical Science 2012; 2(6): 136-143
  • Novel m-component based biomarkers in Waldenström’s Macroglobulinemia.
    Leleu X, Koulieris E, Maltezas D, Itzykson R, Xie W, Manier S, Dulery R, Boyle E, Gauthier J, Poulain S, Tatiana T, Panayiotidis P, Bradwell AR, Harding S, Leblond V, Kyrtsonis MC, Ghobrial IM Clin Lymphoma Myeloma Leuk. 2011;11(1):164-7
CONTACT INFO

CONTACT INFO

+30 210 4809471

Additional Info

  • ΕΙΔΙΚΟΤΗΤΑ Hematologist
Category HEMATOLOGISTS
Read more...
Monday, 18 May 2020 10:50

EVMORFIADIS ILIAS

Written by Νηρέας Θεοδωρακόπουλος
PROFILE

PROFILE

Associate director of the 2nd Haematology clinic, Metropolitan Hospital.

PROFFESSIONAL HISTORY

PROFFESSIONAL HISTORY

  • Feb 2020 - today: Associate director of the 2nd Haematology clinic, Metropolitan Hospital, Piraeus
  • 2019: “Excellence in thrombosis” certification by the “institute for studying & educating about thrombosis and antithrombotic treatment”
  • 2017 - today: Volunteer haematologist in Ag.Stefanos’ social clinic.
  • 2015 - today: Reviewer for “Blood coagulation and fibrinolysis” journal
  • May 2013 - Jan 2020: Haematology consultant for Mediterraneo Hospital, Glyfada, Greece. In charge of haemostasis department/outpatient clinic
  • May 2013 - today: Collaborating with the haemostasis group of “Tenon” university hospital, Paris, France in patient management, studies, congress presentations etc.
  • 2011 - 2012: “Stage de perfectionnement” in haemostasis as an intern, at the “Service d’ Hematologie biologique”, Tenon Hospital Paris (Université Pierre et Marie Curie, Paris VI), France
  • 2010 - 2013: Registrar MD specialising in Haematology in the Haematology Clinic of “Metaxa” Specialised Anti-Cancer Hospital of Piraeus
  • 2008  - 2010: Registrar MD specialising in Haematology in the Haematologic department and the Transfusion Centre of “Aghios Panteleimon” General Hospital of Nikea, Piraeus
  • 2008 - 2008: Volunteer External Scientific Partner for the Haematology clinic of the “Amalia Fleming” General Hospital of Melissia
  • 2006 - 2008: Registrar MD specialising in Internal Medicine in the 1st Internal Medicine Clinic of the “Amalia Fleming” General Hospital of Melissia.
  • 2005 - 2006: SHO residency in internal medicine, general surgery and cardiology at Thebes General Hospital in preparation of the rural medical service and Rural Medical Service at the regional medical station of Pili of Schimatari’s health centre of Thiva’s General Hospital
EDUCATION

EDUCATION

  • 2001 - today Presence in medical seminars & congresses
  • 2008 Issued a Licence to teach English in foreign language schools, by the Secondary Education Office
  • 2003 Recognition of Medical Degree by the Interuniversitary Centre for Recognising Foreign Study Diplomas (DI.K.A.T.S.A) after successfully taking exams in the fields of Internal Medicine & Surgery
  • 2001: Medical Degree from the University of Medicine and Pharmacy “Gr. T. Popa”, Iasi-Romania (English language department)
  • 1995: Highschool Diploma by the General Highschool of Drossia
  • 1994: Awarded the “Cambridge Certificate Of Proficiency In English”
SPOKEN LANGUAGES

SPOKEN LANGUAGES

  • Greek: Fluent (native)
  • English: Fluent
  • Romanian: Fluent
  • French: Limited working proficiency
SCIENTIFIC WORK

SCIENTIFIC WORK

  • 8th Educational Vascular Conference “Prevention - Treatment - Complications of Thromboembolic Disease in the 21st Century” Athens, January 25th 2020, Grand Amphitheater of “Sotiria” hospital, Athens, Greece
  • 7th Interactive Educational Vascular Conference “Venous Thromboembolic Disease versus Effective Treatment. Are you ready?" Athens, 19th of January 2019, Grand Amphitheater of “Sotiria” hospital, Athens, Greece
  • Prospective Assessment of Clinical Risk Factors and Biomarkers of Hypercoagulability for the Identification of Patients with Lung Adenocarcinoma at Risk for Cancer - Associated Thrombosis: The Observational ROADMAP - CAT Study. Oncologist. 2018 Aug 13. pii: theoncologist.2017-0530. doi: 10.1634/theoncologist.2017-0530. [Epub ahead of print]
    Syrigos K, Grapsa D, Sangare R, Evmorfiadis I, Larsen AK, Van Dreden P, Boura P, Charpidou A, Kotteas E, Sergentanis TN, Elalamy I, Falanga A, Gerotziafas GT.
  • 3rd educational symposium of the 1st ICU Clinic of Athens’ university of medicine. Dealing with Respiratory Problems in the Community: Thrombophilia testing after thromboembolic event and the effect of its results on treatment. May 18th-19th 2018, Athens, Greece, Doma Amphitheater, "Evangelismos" general hospital
  • 5th Winter School of Thrombosis - Antithrombotic Education: Understanding the Data of Clinical Studies and Their Impact on Clinical Practice: Co-administration of Antiplatelets and DOACs. Latest data
  • 5th Panhellenic Conference on Thrombosis - Antithrombotic Education: Facts and gaps in the treatment of thromboembolic venous disease in patients with multiple myeloma. September 21st-23rd, 2017, Egli Zappeiou, Athens, Greece
  • ANCA-Negative Churg-Strauss Syndrome Presenting as Acute Multiple Cerebral Infarcts: A Case Report. Journal of Stroke and Cerebrovascular diseases
    Klearchos Psychogios, MD1, Ilias Evmorfiadis, MD2, Spyros Dragomanovits, MD3, Athanasios Stavridis, MD1, Konstantinos Takis, MD1, Loukas Kaklamanis, MD4, and Stathis Pantelis, MD1
  • 5th Educational Angiology day conference, grand amphitheater “Sotiria” Hospital 19/11/2016: VTE Treatment in Thrombophilia (Oral presentation)
  • American Society of Clinical Oncology annual meet.ing, June 3-7 2016, Chicago, Illinois: Identification of clinical variables and biomarkers of hypercoagulability for VTE risk evaluation in ambulatory patients with lung adenocarcinoma on chemotherapy: The ROADMAP study
    Grigoris Gerotziafas, Paraskey Boura, Andriani Charpidou, Ioannis Gkiozos, Ilias Evmorfiadis, Patrick Van Dreden, Aurelie Rousseau, Rabiatou Sangare, Annette K Larsen, Konstantinos N. Syrigos, Ismail Elalamy
  • American Society of Clinical Oncology annual meeting, June 3-7 2016, Chicago, Illinois: A clinico-biological Risk Assessment Model for VTE in ambulatory patients with lung adenocarcinoma on chemotherapy issued from the ROADMAP study
    Grigoris Gerotziafas, Ilias Evmorfiadis, Paraskevi Boura, Patrick Van Dreden, Andriani Charpidou, Aurelie Rousseau, Annette K Larsen, Konstantinos N. Syrigos, Rabiatou Sangare, Ioannis Gkiozos, Ismail Elalamy
  • 2016 ISTH SSC, Montpellier France, May 25-28: Biomarkers of hypercoagulability and clinical variable related with VTE risk in ambulatory patients with lung adenocarcinoma on chemotherapy. The ROADMAP study
    Gerotziafas G1,2, Evmorfiadis I1, Boura P3, Rousseau A4, Charpidou A3, Van Dreden P4, Giozos G3, Grusse M4, Sangate R2, Larsen A2, Syrigos K3 and Elalamy I1,2
  • 2016 ISTH SSC, Montpellier France, May 25-28: Development of a new risk assessment model for VTE specific for ambulatory patients with lung adenocarcinoma on chemotherapy. The ROADMAP study
    Gerotziafas G1,2, Evmorfiadis I3, Van Dreden P4, Boura P5, Rousseau A4, Charpidou A5, Giozos G5, Grusse M4, Larsen A2, Sangare R2, Syrigos K5 and Elalamy I1,2
  • Biennial International Congress on Thrombosis, Istanbul, Turkey - May 4-7, 2016: A NEW RISK ASSESSMENT MODEL FOR VTE IN AMBULATORY PATIENTS WITH LUNG ADENOCARCINOMA ON CHEMOTHERAPY. THE ROADMAP STUDY
    Gerotziafas G, Evmorfiadis I, Boura P, Giozos G, Charpidou A, Rousseau
    A, Van Dreden P, Grusse M, Annette Larsen, Syrigos K, Ismail Elalamy
  • Biennial International Congress on Thrombosis, Istanbul, Turkey - May 4-7, 2016: SELECTION OF BIOLOGICAL MARKERS OF HYPERCOAGULABILITY FOR THE IDENTIFICATION OF HIGH VTE RISK PATIENTS WITH LUNG ADENOCARCINOMA. THE ROADMAP STUDY
    I. Evmorfiadis, P. Boura, A. Rousseau, A. Charpidou, G. Giozos, P. Van
    Dreden, K. Syrigos, A. Larsen, Ismail Elalamy, G. T. Gerotziafas
  • 8th ICTHIC, April 8-10, 2016 Bergamo, Italy: Prospective evaluation of risk assessment models and biological markers of hypercoagu-lability for the identification of high VTE risk patients with lung adenocarcinoma. The ROADMAP study Thromb Res.
    2016 Apr;140 Suppl 1:S196. doi: 10.1016/S0049-3848(16)30186-4. Epub 2016 Apr 8.
    P. Boura, I. Evmorfiadis, A. Rousseau, A. Charpidou, G. Giozos, P. Van Dreden, K. Syrigos, A. Larsen, I. Elalamy, G. T. Gerotziafas (Greece, France)
  • ISTH 2015 Congress, Toronto, June 20-25: Prospective Evaluation of Risk Assessment Models and Biological Markers of Hypercoagulability for the Identification of High VTE Risk Patients With Lung Adenocarcinoma. The ROADMAP Study.
    Ilias Evmorfiadis1,2,5, Paraskevi Boura3, Aurélie Rousseau1,2,4, Ariadni Charpidou2, Giannis Giozos2, Patrick Van Dreden4, Konstantinos Syrigos2, Anastasia Spanoudaki5, Matthieu Grusse4, Ismail Elalamy 1,2 and Grigoris T. Gerotziafas1,2

    56th American Society of Hematology Annual Meeting and Exposition, San Francisco, CA, 6-9 December 2014: Differential Influence of Lung Cancer Stage, Time from Diagnosis and Chemotherapy on Plasma and Cellular Biomarkers of Hypercoagulability. The ROADMAP Study
    Ilias Evmorfiadis1, Paraskevi Boura2, Aurélie Rousseau3,1, Ariadni Charpidou2, Giannis Giozos2, Patrick Van Dreden, PhD4, Konstantinos Syrigos2, Anastasia Spanoudaki5, Matthieu Grusse3, Ismail Elalamy, MD6,5, and Grigorios T. Gerotziafas7,5
  • 55th American Society of Hematology Annual Meeting and Exposition, New Orleans 7-10 December 2013: A Synthetic Evaluation Of Genetic and Pharmacological Resistance To Clopidogrel and On Treatment Residual Platelet Aggregation In Patients With Atherothrombosis
    Grigoris T Gerotziafas1,2*, Severin Bouffard3*, Patrick Van Dreden, Ph.D.4, Amir Kartechi5*, Ilias Evmorfiadis6*, Marie-Paule Roman3*, Vassiliki Galea3,6*, Dimitra Karipidi6* and Ismail Elalamy, MD7,8*
  • 2nd Educational Workshop in Angiology, November 16, 2013, Grand Amphitheatre of "Sotiria" hospital, Athens
    Thrombophilia treatment
    Ilias Evmorfiadis, Gregory Gerotziafas
  • 8th International Congress on Vascular Dementia & The First Cognitive Impairment European Meeting, Athens, Greece, October 17-20, 2013
    Anticoagulant & Antiplatelet Treatment in Dementia Patients, a puzzling question
    I.Evmorfiadis1, N.G. Tsamopoulos2, G.T. Gerotziafas3
  • Publication on «Haema» October – December 2011, Vol. 2-Issue 4, notices for publication:
    Massive lymphadenopathy due to Castleman’s disease: Four case-presentations
    I. Evmorfiadis1, I. Patsias1, Α. Konstantinou1, Μ. Plega1, Μ. Stamouli1, Κ. Galani2, Κ. Ntatsis3, Ι. Iakovidou2, E. Megalakaki1
  • Publication on «Haema» – December 2011, Vol. 2-Issue 4, notices for publication:
    Immunoglobulin levels and infections in Multiple Myeloma patients, on two different Bortezomib-based chemotherapeutic groups
    Α. Konstantinou1, Μ. Stamouli1, I. Evmorfiadis1, I. Patsias1, V. Chatziantoniou1, Μ. Dadakaridou1, Ν. Tragomallos3, Μ. Aslanidou2, Ε. Sotiropoulou2, Μ. Kotsopoulou1, P. Repousis1, E. Megalakaki1
  • Letter to the editor, journal of Balkan Union of Oncology:
    “Castleman disease and adenocarcinoma” vol. 16, no. 4, 2011, pp 781-782, issue of J BUON
    A. Megalakaki1, I. Evmorfiadis1, M. Stamouli1, N. Zakopoulou2, I. Iacovidou3
  • Internal Medicine Days 2011, Athens, 15-16 April 2011:
    New flu caused by H1N1: Clinical features in patients with haematologic diseases
    E.Konstantinou1, Μ.Stamouli1, F.Katis1, G.Papageorgiou1, I.Evmorfiadis1, E.Lamprou2, V.Papaemmanouil2, Μ.Kotsopoulou1, P.Repousis1, E.Megalakaki1
  • 21st Hellenic Haematology Congress, Thessaloniki, 10-12 November 2010:
    DEFINING THE ACTIVITY OF MICROVESICLES IN PATIENTS WITH Ph(-) MYELOPROLIFERATIVE NEOPLASIAS
    I. Patsias1, I. Evmorfiadis1, E. Kalagiakou1, A. Tsiampouris1, E. Samaridis1, G. Papadopoulos2, E. Kalouda1, L. Fountoulaki2, E. Manioudaki1, N. Laoutaris1
  • 21st Hellenic Haematology Congress, Thessaloniki, 10-12 November 2010:
    PLATELET FUNCTION STUDY IN PATIENTS WITH Ph(-) MYELOPROLIFERATIVE NEOPLASIAS. CORRELATION WITH THE MUTATED JAK-2 COPIES LOAD AND THE PRESENCE OF THROMBOTIC EPISODES
    E. Kalagiakou1, I. Evmorfiadis1, A. Tsiambouris1, M. Chatzouli1, I. Patsias1, K. Vallianatou1, E. Sotiropoulou2, A. Zefkilis1, C Belessi1, L. Fountoulaki2, N. Laoutaris1, E. Manioudaki1
  • 6th Hellenic Transfusion Therapy Congress, Ioannina 22-24 April 2010
    CHARACTERISTICS OF REPLACEMENT BLOOD DONORS
    Sotiropoulou E., Evmorfiadis I., Papadopoulos G., Fakitsa V., Stamoulis K., Fountoulaki-Paparizou L.
    Transfusion Centre of G.H. of Nikea-Piraeus “Ag.Panteleimon”
  • 14th EHA Congress, June 4-7 2009, Berlin, Germany:
    JAK2 V617 ALLELE BURDEN AND THROMBOSIS IN PATIENTS WITH POLYCYTHEMIA VERA AND ESSENTIAL THROMBOCYTHEMIA
    E. Kalagiakou ,I. Evmorfiadis ,M. Hatzouli ,E. Manioudaki ,M. Kotsopoulou ,S. Malegkou ,K. Vallianatou ,I-D. Triantafyllopoulou ,E. Samaridis ,L. Dadiotis ,Ch. Mitsouli ,C. Belessi ,N. Laoutaris
  • 19th Hellenic Haematology Congress, Athens 19-22 November 2008
    TREATING del 5q MYELODYSPLASTIC SYNDROMES WITH LOW DOSE LENALIDOMIDE
    E. Manioudaki1, I. Evmorfiadis1,E. Kalagiakou1, K. Vallianatou1, E. Samaridis1, E. Nikolarou1, P. Pantoula2, G. Erotokritou1, A. Parasi2, K. Sampani3, N. Laoutaris1
  • 19th Hellenic Haematology Congress, Athens 19-22 November 2008
    LABORATORY AUTOMATION WITH SYSMEX AUTOMATED HAEMATOLOGIC ANALYSERS & THEIR FUNCTIONS IN CLINICAL PRACTICE
    Nikolaos Laoutaris, Ilias Evmorfiadis
  • May 2008: Co-author of the book “The Diabetic Foot”
    Medical Publications G.V. Pasisianou, Scientific Editor-Responsible for the publication: Dr. Dimitrios E. Vogiatzoglou
  • 13th Hellenic Internal Medicine Congress, Athens 8th -13th October 2007:
    SYMPTOMATIC HYPOGLYCAEMIA & SELECTIVE SEROTONIN REUPTAKE INHIBITORS
    Dimitrios Papavasiliou1, Vasiliki Dimakopoulou1, Evaggelos Rotas1, Sotirios Georgiou1, Ilias Evmorfiadis1, Evaggelos Neroutsos2, Konstantinos Christopoulos1, Dimitrios Vogiatzoglou1
    1. 1st Pathologic Dept. G. H. Melissia “Amalia Fleming”, 2 Psychiatric Dept. G. H. Elefsina “Thriasio”
  • 3rd Hellenic Congress on Wound & Ulcers:
    EXPERIENCE OF 9-YEAR FUNCTION OF DIABETIC FOOT STUDY-THERAPY PRACTICE. PATIENT’S CLINICAL CHARACTERISTICS
    Evmorfiadis I, Volonakis S, Mitsouras K, Renieris I, Vogiatzoglou E, Karagiorgos P,
    Vogiatzoglou D.
  • Switch in X-inactivation in a JAK2 V617F-negative case of polycythemia vera with two acquired X-autosome translocations.
    Leukemia Research July 2007 (Vol. 31, Issue 7, Pages 1009-1014)
    K. Manola, C. Stavropoulou, V. Georgakakos, K. Zoi, M. Fisfis, I. Evmorfiadis, C. Zoi, G. Pantelias, K. Stefanoudaki,
    C.Sambani
CONTACT

CONTACT

Email: evmorfiadis@gmail.com

Telephone: 210 4809 471

 

Additional Info

  • ΕΙΔΙΚΟΤΗΤΑ Associate director, Hematologist
  • PHONE 210 4809 471
Category HEMATOLOGISTS
Read more...
Tuesday, 27 June 2017 15:58

POZIOPOULOS CHRISTOS

Written by Kostas Anagnostopoulos
PROFILE

PROFILE

Associate Director, Hematology Clinic

PREVIOUS EXPERIENCE

PREVIOUS EXPERIENCE

  • 09/1984-09/1987: Specialty training, 401 General Military Hospital of Athens
  • 09/1987-09/1993: Specialty training in Hematology, Athens University 1st Internal Medicine Clinic, Laiko Hospital
  • 10/1993-09/1996: Director, Department of Hematology, Military Veterans' Fund Hospital (NIMTS)
  • 09/1996-09/1998: Postgraduate training, Royal Free Hospital of London, Bone Marrow Transplant Programme
  • 09/1998-09/2003: Director, Hematology and Blood Bank Clinic, 401 General Military Hospital of Athens
  • 09/2003-09/2004: Director, General Military Hospital of Chios
  • 09/2004-02/2009: Director, 1st Internal Medicine Clinic & Hematology Clinic, 401 General Military Hospital of Athens
SCIENTIFIC ACTIVITIES

SCIENTIFIC ACTIVITIES

  • 10/1998-currently: Private practice
  • 02/2010-currently: Scientific Associate, Athens University 1st Internal Medicine Clinic, Laiko Hospital, educational work
  • Member of the Hellenic Society of Hematology (HSH) and the American Society of Hematology (ASH)
  • Participation in international research protocols (CAMN107A2408 in Chronic Myeloid Leukemia, ML22235 for Chronic Lymphocytic Leukemia and MABEASE for B Non-Hodgkin Lymphomas)
  • Long-term and daily activities in the investigation and treatment of all malignant hematologic diseases (acute and chronic lymphocytic and myeloid leukemia, Non-Hodgkin and Hodgkin lymphomas, multiple myelomas and plasmacytic dyscrasias, chronic myelohyperplastic diseases, aplastic anemia, autologous hematopoietic cell transplantation) and all benign diseases (anemia, erythrocytosis, leukocytes, thrombocytopenia and thrombocytosis, congenital and acquired diseases) as well as a clotting and hemostasis disorders (hemorrhagic disposition and thrombophilia, congenital and acquired)
  • Article writing for the HAEMA journal of the Hellenic Society of Hematology
  • Participation in Greek and international conferences (ASH, EHA) with posted and oral announcements
CONTACT

CONTACT

E-mail: cpozi@otenet.gr

Telephone: +30 210 4809 989, +30 210 4809 472

Additional Info

  • ΕΙΔΙΚΟΤΗΤΑ Director, Hematologist
  • PHONE +30 210 4809 989, +30 210 4809 472
Category HEMATOLOGISTS
Read more...
Tuesday, 27 June 2017 15:58

ROMPOS IOANNIS

Written by Kostas Anagnostopoulos
PROFILE

PROFILE

Director, Hematologist

EDUCATION

EDUCATION

  • 1974: Faculty of Medicine, National and Kapodistrian University of Athens
  • 1980: Specialty in Internal Medicine
  • 1983: Specialty in Hematology
  • 1983: PhD, Faculty of Medicine, National and Kapodistrian University of Athens
  • 1985: Postgraduate Training in Bone Marrow Transplantation, Postgraduate Medical School, Hammersmith Hospital, London

Scholarships:

  • 1980: Fellow Scholarship from the Alexander Onassis Foundation for his doctoral dissertation
  • 1985: Fellow Scholarship from the Alexander Onassis Foundation for his postgraduate training in Bone Marrow Transplantation, Postgraduate Medical School, Hammersmith Hospital, London
SENIOR HOSPITAL/ACADEMIC POSTS

SENIOR HOSPITAL/ACADEMIC POSTS

  • 1986-1989: Head of the Thalassemia Intensive Care Unit, Laiko Hospital
  • 1987-1993: Lecturer of Internal Medicine and Hematology, 1st Internal Medicine Clinic, National and Kapodistrian University of Athens; subject: Bone Marrow Transplantation
  • 1993-2003: Assistant Professor of Internal Medicine and Hematology, 1st Internal Medicine Clinic, National and Kapodistrian University of Athens
  • 2003-2013: Associate Professor of Internal Medicine and Hematology, 1st Internal Medicine Clinic, National and Kapodistrian University of Athens
  • 2002-currently: Director, Hematology Clinic, Metropolitan Hospital
ORGANIZATIONAL & ADMINISTRATIVE WORK

ORGANIZATIONAL & ADMINISTRATIVE WORK

  • 1982-1984: Organization of Thalassaemia Prevention Units in Larisa and Agrinio
  • 1987-2013: Head of organization of graduate and postgraduate courses at the 1st Internal Medicine Clinic, National and Kapodistrian University of Athens
  • 1995-2008: Head of the development of progenitor hematopoietic cell transplantations, Cryobiology Lab, 1st Internal Medicine Clinic, National and Kapodistrian University of Athens
  • 2001: Training Program Committee Chairman, 12th Hellenic Hematology Conference
  • 2003: Participation in the organization of the European School of Hematology (ESH) 6th Training Seminar on Bone Marrow Transplants
  • 2006: Chairman, Organizing and Scientific Committee, 1st Sickle Cell Disease Workshop
  • 2007: Chairman, Organizing and Scientific Committee, 1st Hellenic Congress on Sickle Cell Disease
  • 2008: Chairman, Organizing and Scientific Committee, 2nd Hellenic Congress on Sickle Cell Disease
  • 2009: Chairman, Organizing and Scientific Committee, 3rd Hellenic Congress on Sickle Cell Disease
SCIENTIFIC ACTIVITIES

SCIENTIFIC ACTIVITIES

  • Member of the Hellenic Society of Hematology
  • Elected Board Member of the Hellenic Society of Hematology
  • Member of the WHO Working Group for the psychosocial aspects of Thalassemia and Sickle Cell Anemia (1989-1990)
  • International Collaborative Study Group on Oral Iron Chelators (ICSGOIC)
  • Member of the International Group of Research for Technology Advances in Blood Filtration (1986-1990)
  • Member of the General Medical Council (UK)
  • Member of the European Bone Marrow Transplant Group (EBMT)

Participation in Scientific Meetings

  • Chairman in 40 Greek and 10 international meetings
  • Participated in 95 Greek and 60 international meetings

Editorial Work

  • Editorial Board Advisor, Iatriki Medical Journal
  • Editorial Board Advisor, Hippocrates Medical Journal
  • Editorial Board Advisor, Aima Medical Journal

Books

Book chapters in 3 Greek and 2 international scientific papers

Publications

25 in Greek and 60 in international meetings

Abstracts

105 in Greek and 90 in international meetings

CONTACT

CONTACT

E-mail: yrombos@otenet.gr

Telephone: +30 210 4809 668

Additional Info

  • ΕΙΔΙΚΟΤΗΤΑ Director, Hematologist
  • PHONE +30 210 4809 668
  • E-mail yrombos@otenet.gr
Category HEMATOLOGISTS
Read more...
Tuesday, 27 June 2017 15:58

CHATZIDIMITRIOU - PAPAZACHARIA GRAMMATIKI

Written by Kostas Anagnostopoulos

Additional Info

  • ΕΙΔΙΚΟΤΗΤΑ Director, Hematologist
  • PHONE 210 480 9000
Category HEMATOLOGISTS
Read more...
Tuesday, 27 June 2017 15:58

CHATZILEONIDA EFSTRATIA

Written by Kostas Anagnostopoulos

Additional Info

  • ΕΙΔΙΚΟΤΗΤΑ Registrar, Hematologist
  • PHONE +30 210 480 7040, +30 210 4809 668
Category HEMATOLOGISTS
Read more...
Tuesday, 27 June 2017 15:58

NIKOLAOU EFTICHIA

Written by Kostas Anagnostopoulos

Additional Info

  • ΕΙΔΙΚΟΤΗΤΑ Registrar, Hematologist
  • PHONE +30 210 4809 472
Category HEMATOLOGISTS
Read more...
General Services
Innovative Services
Specialized Units
Check-up
Emergency Department
Ambulances
Outpatient Department
Medical Tourism
Price List
COVID-19 TEST

SEE ALSO

PrevNext
OUTPATIENT DEPARTMENT
The Metropolitan Hospital Outpatient Department covers the entire range of medical specialties. It is open...
OUTPATIENT DEPARTM...
BILLING SUPPORT
The helpful and experienced financial counselors at Metropolitan Hospital will assist you with preparing estimates,...
BILLING SUPPORT
MEDICAL TOURISM
Metropolitan Hospital offers international patients the entire range of medical services available to all Greek...
MEDICAL TOURISM
OUR VISION & MISSION
The vision of the Metropolitan Hospital founders was to establish an innovative hospital, directly linked...
OUR VISION & MISSI...
ABOUT METROPOLITAN
Metropolitan Hospital was founded in 2001 as a part of PERSEUS Healthcare Group SA and...
ABOUT METROPOLITAN...
FACILITIES & EQUIPMENT
PERSEUS Group does not consider top-quality services a luxury, but a basic obligation to patients....
FACILITIES & EQUIP...
QUALITY & PATIENT SAFETY
  OUR VISION By using proven, modern and effective treatments, and providing integrated services of superior quality,...
QUALITY & PATIENT ...
PRIVATE AMBULANCES
Metropolitan Hospital is equipped with 5 ambulances. We rush to your side wherever you needs...
PRIVATE AMBULANCES...
CHECK-UP
Preventive medicine has been Metropolitan Hospital’s key objective since the first year of its operation....
CHECK-UP
EMERGENCY DEPARTMENT
The fully staffed Emergency Department is on alert 24/7 and equipped to handle any medical...
EMERGENCY DEPARTME...

Νοσοκομείο Metropolitan

Book your appointment online quickly and easily!

REQUEST AN APPOINTMENTPRICE LIST

GIVING IT

ALL FOR

YOUR HEALTH

ΣΥΝΔΕΣΗ/ΑΠΟΣΥΝΔΕΣΗ

© 2025 Metropolitan Hospital
Web Design by CnC Tech & Ruler

ADDRESS

9 Ethnarchou Makariou & 1 E. Venizelou

GR-18547 Neo Faliro

EMERGENCY (24/7)

CALL CENTER 210 4809000

AMBULANCE 210 4809102

APPOINTMENT

TELEPHONE 2104809150 -160

CERTIFICATIONS

Temos Excellence in Medical Tourism Temos Quality in International Patient Care  ISO 2200 DC Preferred Partner Hospital 2019 ISO 9001

OFFICIAL SPONSOR

σύνδεσμος ελληνικών γυμναστικών αθλητικών σωματείωνΣύλλογος Ελλήνων ΟλυμπιονικώνΣύλλογος Ελλήνων Ολυμπιονικών